Autograft-sparing products for definitive care of burn injuries

Ended Definitive Contract Awarded Last action

Contract number
HHSO100201500028C
Awardee
Awarding agency
Obligated
$40,800,433

Award facts

Opportunity
Contract value 42% obligated
  • $40,800,433.00 Current, with exercised options
  • $96,424,222.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Northridge, CA 91324, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00017 -$12,532,518
Change Order P00016 -$3,556
Change Order P00015 $12,000,000
Change Order P00014 -$12,000,000
Change Order P00013 $0
Change Order P00011 $0
Other Administrative Action P00012 $0
Change Order P00010 $0
Supplemental Agreement for work within scope P00009 $0
Other Administrative Action P00008 $0
Other Administrative Action P00007 $0
Supplemental Agreement for work within scope P00006 $1,611,686
Other Administrative Action P00005 $1,310,684
Funding Only Action 4 $1,236,593
Exercise an Option 3 $24,317,466
Change Order 2 $7,958,654
Other Administrative Action 1 $0
Original award $16,901,424
Show all 18

About this award

Written by GovTribe AI ·

The Office of the Assistant Secretary for Preparedness and Response (ASPR) awarded a definitive cost-plus-fixed-fee contract to Avita Medical Americas, LLC, a small business, on September 29, 2015, for the provision of autograft-sparing products to support the definitive care of burn injuries. The contract carries a ceiling value of $96.4 million and is scheduled for completion by December 31, 2028. Work will be performed in Northridge, California. Avita Medical Americas specializes in regenerative medicine through its flagship RECELL System, an innovative device that enables healthcare professionals to produce a spray-on skin suspension from a patient's own skin cells, significantly reducing the need for donor skin while accelerating healing times and reducing hospital stays.

The RECELL Autologous Cell Harvesting System represents a significant advancement in burn care treatment by leveraging the patient's own cellular material for wound healing. This small-business set-aside contract aligns with ASPR's mission to enhance preparedness and response capabilities across the civilian healthcare system, building on proven applications of the technology within the Department of Defense's burn care programs. The extended performance period through 2028 supports sustained supply and continued availability of these regenerative medicine products for treating burn injuries across the federal healthcare system.

Quick answers

Who was awarded contract HHSO100201500028C?

HHSO100201500028C was awarded to Avita Medical Americas, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 29, 2015.

How much is contract HHSO100201500028C worth?

The government has obligated $40,800,433 on HHSO100201500028C. Its potential value, with all options, is $96,424,222.

Was contract HHSO100201500028C competed?

The extent of competition for HHSO100201500028C was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award
Try for free Login